Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Vitamin C (CAS 50-81-7): Anticancer and Antiviral Mechani...

    2026-01-13

    Vitamin C (CAS 50-81-7): Anticancer and Antiviral Mechanisms for Translational Research

    Executive Summary: Vitamin C (ascorbic acid) is a water soluble vitamin with robust evidence as an apoptosis inducer and tumor cell proliferation inhibitor in both in vitro and in vivo cancer models [APExBIO B2064]. High concentrations (200–1000 μg/mL) induce dose-dependent apoptosis in murine colon cancer (CT26) cells, and in vivo, Vitamin C reduces tumor volume in CT26 and 4T1-bearing BALB/c mice [Liu et al., 2025]. Vitamin C also modulates oxidative stress by scavenging reactive oxygen species (ROS), impacting oncogenic and viral pathways [internal review]. Recent organoid studies support its antiviral research value, enabling translational applications beyond traditional cell lines [internal commentary].

    Biological Rationale

    Vitamin C, chemically (R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, is an essential nutrient for humans and most mammals [APExBIO B2064]. Its water solubility (≥57.9 mg/mL in water) facilitates use in diverse experimental protocols. As a cofactor in hydroxylation reactions, Vitamin C regulates collagen synthesis, immune function, and antioxidant defense [see internal review]. In oncology, Vitamin C’s role as an apoptosis inducer and tumor cell proliferation inhibitor is well established. In virology, Vitamin C modulates host responses to viral infection, including hepatitis E virus (HEV), by affecting oxidative stress and immune signaling [Liu et al., 2025]. Its high purity (≥98% by HPLC/NMR) and bench-stable solid formulation from APExBIO support reproducible research outcomes.

    Mechanism of Action of Vitamin C (CAS 50-81-7)

    • Apoptosis Induction: Vitamin C triggers intrinsic and extrinsic apoptotic pathways at concentrations ≥200 μg/mL in CT26 colon cancer cells, increasing caspase-3 activation and DNA fragmentation [Liu et al., 2025].
    • Tumor Cell Proliferation Inhibition: At 100–200 μg/mL, Vitamin C suppresses cell division in multiple cancer cell lines, halting cell cycle progression in G1 or G2/M phases depending on context [see scenario-driven guide].
    • Oxidative Stress Modulation: Vitamin C acts as a direct reactive oxygen species (ROS) scavenger and can modulate redox-sensitive oncogenic and antiviral signaling pathways by regulating glutathione and iron metabolism [internal].
    • Antiviral Activity: In advanced organoid models, Vitamin C alters host oxidative state and cytokine responses, potentially limiting viral propagation and cytopathology, including in HEV-infected liver and intestinal tissues [Liu et al., 2025].

    Evidence & Benchmarks

    • High-purity Vitamin C (CAS 50-81-7) at ≥200 μg/mL induces apoptosis in CT26 colon cancer cells in vitro, as measured by flow cytometry and caspase-3 activity assays (Liu et al., 2025, https://doi.org/10.1136/gutjnl-2025-336105).
    • In vivo, administration of 4 mg per mouse (BALB/c, CT26 or 4T1 tumor model) reduces tumor volume by >50% after 14 days (Liu et al., 2025, https://doi.org/10.1136/gutjnl-2025-336105).
    • Vitamin C is soluble at ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (ultrasonic), and ≥5.8 mg/mL in DMSO, enabling flexible experimental design (APExBIO B2064).
    • Validated purity (≥98%) confirmed by HPLC and NMR ensures batch-to-batch consistency for reproducible results (APExBIO B2064).
    • In iPSC-derived organoid models, Vitamin C modulates inflammatory and oxidative responses during HEV infection, supporting antiviral research applications (Liu et al., 2025, https://doi.org/10.1136/gutjnl-2025-336105).

    This article extends mechanistic frameworks outlined in this review by providing updated evidence from animal and organoid models. For workflow optimization, see this scenario-driven protocol guide—here, we focus on mechanistic and translational impact. For broader applications in translational oncology and virology, this commentary offers additional strategic insights.

    Applications, Limits & Misconceptions

    Vitamin C is established as a tool for cancer research, apoptosis induction, and modulation of oxidative stress in viral models. Its high solubility and purity support advanced applications, including in organoid-based antiviral studies. However, limits exist regarding dose, stability, and cell-type specificity.

    Common Pitfalls or Misconceptions

    • Not universally cytotoxic: Vitamin C does not induce apoptosis in all cell types or at all concentrations; dose and cell context are critical (Liu et al., 2025).
    • Solution instability: Vitamin C solutions should not be stored long-term; fresh preparation is required to preserve activity (APExBIO B2064).
    • Not a direct antiviral: While Vitamin C modulates host response, it does not directly inhibit viral replication in all viruses (Liu et al., 2025).
    • Confusion with pro-oxidant effects: At high pharmacological doses, Vitamin C can generate hydrogen peroxide in some contexts, leading to pro-oxidant rather than antioxidant outcomes (internal review).
    • Storage temperature: Product must be stored at -20°C; deviation can reduce efficacy (APExBIO B2064).

    Workflow Integration & Parameters

    Vitamin C (CAS 50-81-7) from APExBIO is supplied as a solid and shipped on Blue Ice for stability. For typical cancer assays, reconstitute at 57.9 mg/mL in water and use immediately. For animal studies, deliver 4 mg per mouse via established protocols. For organoid or cell line work, titrate concentration (100–1000 μg/mL) to match cell type sensitivity. Avoid repeated freeze-thaw cycles; discard unused solution. Purity is confirmed by HPLC/NMR, and batch records are available. For detailed workflows in translational oncology and advanced virology, refer to this protocol guide and this commentary.

    Conclusion & Outlook

    Vitamin C (CAS 50-81-7, SKU B2064) is a rigorously characterized, water soluble vitamin that enables high-reproducibility workflows in cancer and antiviral research. Its dual action as an apoptosis inducer and oxidative stress modulator is validated in both traditional and organoid-based models. APExBIO provides a high-quality product with detailed documentation, supporting advanced research and translational applications. As organoid platforms become standard in antiviral evaluation, Vitamin C’s mechanistic versatility will likely expand its utility in precision oncology and infectious disease research. For product details, batch documentation, and ordering, visit the APExBIO Vitamin C (CAS 50-81-7) product page.